Frontlight ResearchEarly access
Trial site
Johor Bahru
- 7running trials
- 2closed trials
The trials here
What the 9 trials at this site are about, from their registry records.
- Conditions
- Immune thrombocytopenia (ITP)3 trials
- Chronic myeloid leukaemia2 trials
- Hidradenitis suppurativa2 trials
- Myeloproliferative neoplasms2 trials
- Acute lymphoblastic leukaemia1 trial
- Childhood cancers1 trial
- Coronary artery disease1 trial
- Familial hypercholesterolaemia1 trial
- Stroke1 trial
- Phase
- Phase 37 trials
- Phase 21 trial
- Phase 41 trial
- Status
- Active, not recruiting5 trials
- Completed2 trials
- Recruiting2 trials
- Lead sponsor
- Novartis Pharmaceuticals9 trials
Running trials
Recruiting
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Myeloproliferative neoplasms2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 18 Nov 2026